Trial Outcomes & Findings for Oral Cell DNA Adducts in Smokers (NCT NCT03285893)
NCT ID: NCT03285893
Last Updated: 2024-11-12
Results Overview
Acrolein-DNA adduct (8R/S)-3-(2'-deoxyribos-1'-yl)-5,6,7,8-tetrahy- dro-8-hydroxypyrimido\[1,2-a\]purine-10(3H)-one. Model adjusted for age, sex and race/ethnicity
COMPLETED
281 participants
Baseline
2024-11-12
Participant Flow
Participant milestones
| Measure |
Native Hawaiian Cigarette Smokers
oral cell DNA adducts
oral cell DNA adducts: oral cells will be collected, DNA isolated, and analyzed for adducts
|
White (European Americans) Cigarette Smokers
oral cell DNA adducts
oral cell DNA adducts: oral cells will be collected, DNA isolated, and analyzed for adducts
|
Japanese American Cigarette Smokers
oral cell DNA adducts
oral cell DNA adducts: oral cells will be collected, DNA isolated, and analyzed for adducts
|
|---|---|---|---|
|
Overall Study
STARTED
|
101
|
101
|
79
|
|
Overall Study
COMPLETED
|
101
|
101
|
79
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Oral Cell DNA Adducts in Smokers
Baseline characteristics by cohort
| Measure |
Native Hawaiian Cigarette Smokers
n=101 Participants
oral cell DNA adducts
oral cell DNA adducts: oral cells will be collected, DNA isolated, and analyzed for adducts
|
White (European Americans) Cigarette Smokers
n=101 Participants
oral cell DNA adducts
oral cell DNA adducts: oral cells will be collected, DNA isolated, and analyzed for adducts
|
Japanese American Cigarette Smokers
n=79 Participants
oral cell DNA adducts
oral cell DNA adducts: oral cells will be collected, DNA isolated, and analyzed for adducts
|
Total
n=281 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
45.5 years
STANDARD_DEVIATION 17.7 • n=5 Participants
|
47.5 years
STANDARD_DEVIATION 15.7 • n=7 Participants
|
59.2 years
STANDARD_DEVIATION 14.6 • n=5 Participants
|
50.1 years
STANDARD_DEVIATION 16.1 • n=4 Participants
|
|
Sex: Female, Male
Female
|
53 Participants
n=5 Participants
|
49 Participants
n=7 Participants
|
26 Participants
n=5 Participants
|
128 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
48 Participants
n=5 Participants
|
52 Participants
n=7 Participants
|
53 Participants
n=5 Participants
|
153 Participants
n=4 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
79 Participants
n=5 Participants
|
79 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
101 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
101 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=5 Participants
|
101 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
101 Participants
n=4 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
PRIMARY outcome
Timeframe: BaselineAcrolein-DNA adduct (8R/S)-3-(2'-deoxyribos-1'-yl)-5,6,7,8-tetrahy- dro-8-hydroxypyrimido\[1,2-a\]purine-10(3H)-one. Model adjusted for age, sex and race/ethnicity
Outcome measures
| Measure |
Native Hawaiian Cigarette Smokers
n=101 Participants
oral cell DNA adducts
oral cell DNA adducts: oral cells will be collected, DNA isolated, and analyzed for adducts
|
White (European Americans) Cigarette Smokers
n=101 Participants
oral cell DNA adducts
oral cell DNA adducts: oral cells will be collected, DNA isolated, and analyzed for adducts
|
Japanese American Cigarette Smokers
n=79 Participants
oral cell DNA adducts
oral cell DNA adducts: oral cells will be collected, DNA isolated, and analyzed for adducts
|
|---|---|---|---|
|
Concentration of γ-OH-Acr-dGuo, a Major Acrolein-DNA Adduct
|
49.7 10^9 nucleotides/mL
Interval 41.2 to 59.9
|
67.1 10^9 nucleotides/mL
Interval 55.7 to 80.7
|
46.5 10^9 nucleotides/mL
Interval 37.2 to 58.0
|
SECONDARY outcome
Timeframe: BaselineLipid peroxidation-related adduct 1,N6-etheno-dAdo etheno-DNA adducts from peroxidation of lipids. Model adjusted for age, sex and race/ethnicity
Outcome measures
| Measure |
Native Hawaiian Cigarette Smokers
n=101 Participants
oral cell DNA adducts
oral cell DNA adducts: oral cells will be collected, DNA isolated, and analyzed for adducts
|
White (European Americans) Cigarette Smokers
n=101 Participants
oral cell DNA adducts
oral cell DNA adducts: oral cells will be collected, DNA isolated, and analyzed for adducts
|
Japanese American Cigarette Smokers
n=79 Participants
oral cell DNA adducts
oral cell DNA adducts: oral cells will be collected, DNA isolated, and analyzed for adducts
|
|---|---|---|---|
|
εdAdo, Per 10^9 Nucleotides
|
11.3 10^9 nucleotides/mL
Interval 9.9 to 12.9
|
11.3 10^9 nucleotides/mL
Interval 9.94 to 12.9
|
9.16 10^9 nucleotides/mL
Interval 7.83 to 10.7
|
Adverse Events
Native Hawaiian Cigarette Smokers
White (European Americans) Cigarette Smokers
Japanese American Cigarette Smokers
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place